IR
AVNS

Invictus RG’s Avanos Medical AVNS Stock Holding History

Invictus RG’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,486
Closed -$307K – 20
2018
Q3 		$307K Buy
+4,486
New +$289K 0.24% 117
2018
Q1 		– Sell
-7,504
Closed -$347K – 231
2017
Q4 		$347K Buy
7,504
+6,440
+605% +$296K 0.37% 121
2017
Q3 		$48K Sell
1,064
-6,381
-86% -$272K 0.04% 373
2017
Q2 		$292K Buy
7,445
+2,896
+64% +$109K 0.21% 192
2017
Q1 		$173K Sell
4,549
-5,850
-56% -$228K 0.12% 347
2016
Q4 		$385K Buy
+10,399
New +$372K 0.26% 132

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Invictus RG's AVNS Position: Q4 2018 in Review

Invictus RG sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 4,486 shares — an estimated $307K sold.

Invictus RG first reported a position in AVNS in Q4 2016 and held it in 6 quarters. The position peaked at $385K in Q4 2016. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Invictus RG reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Invictus RG sold 4,486 Avanos Medical shares in Q4 2018, an estimated $307K.
  • Invictus RG first reported a position in Avanos Medical in Q4 2016 and held it in 6 quarters.
  • Invictus RG's Avanos Medical position peaked at $385K in Q4 2016.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Invictus RG's 13F filing for Q4 2018, filed 13 Feb 2019.